G
GTBP
Gt Biopharma Inc
0.4495
+0.0401+9.79%After Hours: 0.4410 -0.0085 -1.89%19:24 04/02 EDT
OPEN/PREV CLOSE0.4160/0.4094
TODAY RANGE0.4101-0.4495
VOL407.71K
MARKET CAP14.18M
52 WEEK RANGE0.3915-3.850
AVG VOL (3M)1.16M
% TURNOVER1.29%
TURNOVER--
P/E (TTM)-0.0719
% RANGE9.23%
EPS(TTM)-6.2484
P/E(FORWARD)-1.4047
P/B1.984
BVPS0.2266
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP13.63M
SHARES OUTSTANDING31.55M
NEXT EARNINGS05/13-05/18
FREE FLOAT30.32M
LOT SIZE1
EX-DATE02/05/2024
News
Press Releases
Financial Reports
Profile
Barchart·03/11 06:00
GT Biopharma to Participate in the 38th Annual Roth Conference
TipRanks·03/03 13:31
GT Biopharma price target lowered to $3 from $8 at Roth Capital
Seeking Alpha·03/02 19:42
GT Biopharma reports FY results
Benzinga·03/02 14:28
GT Biopharma Q4 EPS $(4.84) Down From $(1.66) YoY
Dow Jones·03/02 12:47
*GT Biopharma: Proforma Cash Balance as of Jan 31 About $9M >GTBP
Dow Jones·03/02 12:46
*GT Biopharma Yr Loss $28.4M >GTBP
TipRanks·03/02 12:12
GT Biopharma expects cash to fund operations through Q4 2026
Dow Jones·03/02 12:06
*GT Biopharma 2025 Research and Development Expenses About $3.5M >GTBP
Reuters·03/02 12:00
GT BIOPHARMA REPORTS FULL YEAR 2025 FINANCIAL RESULTS
Reuters·02/17 12:30
GT Biopharma to Present at Centurion One Capital Toronto Growth Conference
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.